Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis

Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis
p p Read More

New cell therapy shows potential in treating advanced blood disorder

December 10, 2024 News

CatalYm shows potential of visugromab for treating cachexia

CatalYm shows potential of visugromab for treating cachexia
p p Read More

New findings presented at international SCWD conference

December 10, 2024 News

Imfinzi receives NICE recommendation for lung cancer treatment

Imfinzi receives NICE recommendation for lung cancer treatment
p p Read More

Trial results lead to new treatment option for lung cancer

December 9, 2024 News

Poolbeg Pharma presents positive results for POLB 001

Poolbeg Pharma presents positive results for POLB 001
p p Read More

promising pre-clinical data on preventing cytokine release syndrome

December 9, 2024 News

Teva’s Ajovy shows positive results in preventing pediatric migraines

Teva’s Ajovy shows positive results in preventing pediatric migraines
p p Read More

Phase 3 trial indicates significant efficacy and safety for children and adolescents

December 5, 2024 News

NICE endorses Neuraxpharm’s ublituximab for treating MS

NICE endorses Neuraxpharm’s ublituximab for treating MS
p p Read More

New antibody therapy shows promise in managing condition

December 5, 2024 News

Antag Therapeutics secures €80 million in weight loss therapy financing

Antag Therapeutics secures €80 million in weight loss therapy financing
p p Read More

Versant Ventures leads investment round to advance drug

December 4, 2024 News

Everest therapy shows promise in nephropathy trial

Everest therapy shows promise in nephropathy trial
p p Read More

Data highlights effectiveness of EVER001 in treating pMN

December 4, 2024 News

KIMMTRAK recommended for funding by NICE for uveal melanoma patients

KIMMTRAK recommended for funding by NICE for uveal melanoma patients
p p Read More

Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute for […]

December 3, 2024 News

Orbit Discovery and Evergreen Theragnostics expand research collaboration

Orbit Discovery and Evergreen Theragnostics expand research collaboration
p p Read More

Partnership aims to develop new radiopharmaceuticals for cancer treatment

December 3, 2024 News

Posts navigation

Posts pagination

« Previous 1 … 31 32 33 … 73 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy